The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Essential role of ribosomal protein L11 in mediating growth inhibition‐induced p53 activation
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“The tumor suppressor protein p53 plays a pivotal role in preventing damaged or abnormal cells from becoming malignant, and its loss of function is associated with a majority of human cancers (Vogelstein et al, 2000; Ryan et al, 2001).”
BackgroundMdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · cited 1×
“This is accomplished by the proto-oncoprotein HDM2 either through ubiquitin-dependent p53 degradation in the cytoplasm (Haupt et al, 1997; Honda et al, 1997; Kubbutat et al, 1997) or repression of p53 transcriptional activity in the nucleus (Momand et al, 1992; Thut et al, 1997).”
BackgroundRegulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“This is accomplished by the proto-oncoprotein HDM2 either through ubiquitin-dependent p53 degradation in the cytoplasm (Haupt et al, 1997; Honda et al, 1997; Kubbutat et al, 1997) or repression of p53 transcriptional activity in the nucleus (Momand et al, 1992; Thut et al, 1997).”
BackgroundMomand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113 · cited 1×
“This is accomplished by the proto-oncoprotein HDM2 either through ubiquitin-dependent p53 degradation in the cytoplasm (Haupt et al, 1997; Honda et al, 1997; Kubbutat et al, 1997) or repression of p53 transcriptional activity in the nucleus (Momand et al, 1992; Thut et al, 1997).”
BackgroundDNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100 · cited 1×
“Major mechanisms of p53 stabilization and activation include the one that is triggered by DNA damage and induces p53 protein phosphorylation (Shieh et al, 1997; Giaccia and Kastan, 1998; Meek, 1999), or the one in response to aberrant growth signals, such as oncogenic Ras or Myc, which is mediated…”
BackgroundOncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951 · cited 1×
“This is accomplished by the proto-oncoprotein HDM2 either through ubiquitin-dependent p53 degradation in the cytoplasm (Haupt et al, 1997; Honda et al, 1997; Kubbutat et al, 1997) or repression of p53 transcriptional activity in the nucleus (Momand et al, 1992; Thut et al, 1997).”
BackgroundThe p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626
Self-citationmdm2 expression is induced by wild type p53 activity.
Barak, Y., Juven, T., Haffner, R., & Oren, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05678.x · Cited by 1,290
Sherr, C. J., & Weber, J. D. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00038-6 · Cited by 654
Repression of p53-mediated transcription by MDM2: a dual mechanism
Thut, C. J., Goodrich, J. A., & Tjian, R. (1997) · Genes & Development · doi:10.1101/gad.11.15.1974 · Cited by 272
Cited by
MYC as a regulator of ribosome biogenesis and protein synthesis
van Riggelen, J., Yetil, A., & Felsher, D. W. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2819 · Cited by 956
Ribosome biogenesis in cancer: new players and therapeutic avenues
Pelletier, J., Thomas, G., & Volarević, S. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.104 · Cited by 812
How Common Are Extraribosomal Functions of Ribosomal Proteins?
Warner, J. R., & McIntosh, K. B. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.03.006 · Cited by 747
Signaling to p53: ribosomal proteins find their way
Zhang, Y., & Lu, H. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.024 · Cited by 591
Self-citationCoping with stress: multiple ways to activate p53
Horn, H. F., & Vousden, K. H. (2007) · Oncogene · doi:10.1038/sj.onc.1210263 · Cited by 522
Metadata
- Authors
- Bhat, K. P., Itahana, K., Jin, A., & Zhang, Y.
- Venue
- The EMBO Journal
- Published
- 2004-05-20
- Volume
- 23
- Issue
- 12
- Pages
- 2402-2412
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W2158456335
- Cited by
- 248
- References
- 11
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.